Rocaglamide and silvestrol: a long story from anti-tumor to anti-coronavirus compounds.


Journal

Natural product reports
ISSN: 1460-4752
Titre abrégé: Nat Prod Rep
Pays: England
ID NLM: 8502408

Informations de publication

Date de publication:
01 01 2021
Historique:
pubmed: 24 7 2020
medline: 13 2 2021
entrez: 24 7 2020
Statut: ppublish

Résumé

Covering: up to the beginning of 2020Many natural substances have been transformed again and again with regard to their pharmaceutical-medical potential, including new members of a growing class of natural products, the flavaglines. Important representatives are rocaglamide and silvestrol, isolated from the Aglaia species, which are highlighted here. These products started as potential anti-tumor agents five decades ago and have recently proved to be very promising antiviral agents, especially against RNA viruses. Today they are discussed as potential starting compounds for developing drug candidates and therapeutics.

Identifiants

pubmed: 32699874
doi: 10.1039/d0np00024h
doi:

Substances chimiques

Antineoplastic Agents 0
Antiviral Agents 0
Benzofurans 0
Biological Products 0
Triterpenes 0
silvestrol 0
rocaglamide 84573-16-0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

18-23

Auteurs

Göran Schulz (G)

Institute of Organic Chemistry, Leibniz University Hannover, Schneiderberg 1B, 30167 Hannover, Germany. andreas.kirschning@oci.uni-hannover.de.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH